NCT00077584 Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Status COMPLETED Phase PHASE3
NCT00058578 Stem Cell Transplant to Treat Patients With Systemic Sclerosis Status COMPLETED Phase PHASE1
NCT00043706 Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00040651 Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients Status TERMINATED Phase PHASE1
NCT00016458 Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT00010335 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Status COMPLETED Phase PHASE1
NCT00006393 Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis Status UNKNOWN Phase N/A
NCT00004786 Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis Status COMPLETED Phase PHASE3
NCT00004380 Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis Status COMPLETED Phase PHASE2